已收盤 01-09 16:00:00 美东时间
-0.430
-0.57%
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
2025-12-16 09:36
UBS analyst Joshua Chan maintains Exponent (NASDAQ:EXPO) with a Neutral and raises the price target from $76 to $81.
2025-12-16 02:50
Street's 2026 rally hopes hinge on productivity gains. Explore the top future-of-work ETFs poised to benefit from AI, automation, and smart infrastructure.
2025-12-02 05:00
作家、科技界权威乔治·吉尔德(George Gilder)说,有一项新技术将改变世界。他在2000年代末写到,“它正在以远超计算机时代的深刻力量,重塑文化、经济...
2025-11-27 10:40
William Blair analyst Andrew Nicholas upgrades Exponent (NASDAQ:EXPO) from Market Perform to Outperform.
2025-11-17 21:04
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Exponent 2025年第三季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - 总营收:1.471亿美元,同比增长8% - 净营收(扣除报销费用):1.371亿美元,同比增长10% **盈利能力:** - 净利润:2,800万美元,同比增长约7.7%(前年同期2,600万美元) - 每股收益:0.55美元,同比增长10%(前年同期0.50美元) - EBITDA:3,880万美元,同比增长9% - EBITDA利润率:28.3%,较前年同期28.6%略有下降 **运营指标:** - 可计费工时:37.6万小
2025-10-31 12:13
Exponent, Inc. (NASDAQ:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on December 19, 2025 to all common stockholders of record as
2025-10-31 04:18
Exponent (NASDAQ:EXPO) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.51 by 8.48 percent. This is a 10 percent increase over earnings of $0.50 per share from the same
2025-10-31 04:09
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
2025-10-30 19:12
Caesars Entertainment (NASDAQ:CZR) fell in early trading on Wednesday after falling short of estimates with its third-quarter earnings report. Revenue was flat compared to a year ago at $2.87 billion....
2025-10-29 19:14